Skip to Main Content

Paper Details

Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI.
J Am Heart Assoc
23
2022
Icosapent Ethyl, Icosapent ethyl, Patients, REDUCE, cardiovascular death, cardiovascular events, cholesterol, icosapent ethyl, low-density lipoprotein cholesterol, nonfatal myocardial infarction, nonfatal stroke, patients, statins, triglycerides, unstable angina
Author NameAffiliation
Deepak L BhattBrigham and Women's Hospital Heart and Vascular Center Harvard Medical School Boston MA.
Duane S PintoBaim Clinical Research Institute Boston MA.
Robert P GiuglianoBrigham and Women's Hospital Heart and Vascular Center Harvard Medical School Boston MA.
Matthew J BudoffDavid Geffen School of Medicine Lundquist Institute Torrance CA.
Jean-Claude TardifMontreal Heart InstituteUniversite de Montreal Quebec Canada.
Christie M BallantyneDepartment of Medicine Baylor College of MedicineCenter for Cardiovascular Disease PreventionMethodist DeBakey Heart and Vascular Center Houston TX.
Christie M BallantyneDepartment of Medicine Baylor College of MedicineCenter for Cardiovascular Disease PreventionMethodist DeBakey Heart and Vascular Center Houston TX.
  • 1 - 7

Datasets

Release 1.2